ORIGINALARTICLE Examining the links between COVID-19 seropositivity, metabolic syndrome and depressive symptoms: evidence from ENSANUT 2021 – 2022
Examination of the independent and combined effects of COVID-19 seropositivity and metabolic syndrome on depressive symptoms, considering demographic and health-related factors concluded that the former was associated with higher odds of depressive symptoms and the latter with increased CESD-7 scores.